k8¿­·¢(Öйú)

ÕâÊÇÃèÊöÐÅÏ¢

ÐÂÎÅ×ÊѶ

ÐÂÎÅ×ÊѶ
ÁôÑÔ×Éѯ
Óë×îÐÂÏûÏ¢±£´æͬ²½
/
/
ÈçºÎÕë¶ÔÍâÃÚÌåĤµ°°×Õ¹¿ªÈ«·½Î»Ñо¿£¿£¨ÏÂƪ£©

ÈçºÎÕë¶ÔÍâÃÚÌåĤµ°°×Õ¹¿ªÈ«·½Î»Ñо¿£¿£¨ÏÂƪ£©

¡¾¸ÅÒªÃèÊö¡¿ÉÏƪÎÒÃǽéÉÜÁËÍâÃÚÌåĤµ°°×¿ÉÒÔ×÷Ϊ°ÐÏòÔËÊä·Ö×Ó¼°ÔØÒ©Ö§¼Ü·Ö×Ó£¬½ñÌìÎÒÃǼÌÐøͨ¹ýÁ½Æª¾«²Ê°¸Àý½éÉÜÍâÃÚÌåĤµ°°×µÄÁÙ´²Ó¦ÓÃDZÄÜ¡£

ÈçºÎÕë¶ÔÍâÃÚÌåĤµ°°×Õ¹¿ªÈ«·½Î»Ñо¿£¿£¨ÏÂƪ£©

¡¾¸ÅÒªÃèÊö¡¿ÉÏƪÎÒÃǽéÉÜÁËÍâÃÚÌåĤµ°°×¿ÉÒÔ×÷Ϊ°ÐÏòÔËÊä·Ö×Ó¼°ÔØÒ©Ö§¼Ü·Ö×Ó£¬½ñÌìÎÒÃǼÌÐøͨ¹ýÁ½Æª¾«²Ê°¸Àý½éÉÜÍâÃÚÌåĤµ°°×µÄÁÙ´²Ó¦ÓÃDZÄÜ¡£

  • ·ÖÀࣺ»ªÓ¯ÊÓ½Ç
  • ×÷ÕߣºÈðÈð
  • À´Ô´£º
  • ·¢²¼Ê±¼ä£º2022-04-22 13:25
  • ·ÃÎÊÁ¿£º
ÏêÇé

ÉÏƪÎÒÃǽéÉÜÁËÍâÃÚÌåĤµ°°×¿ÉÒÔ×÷Ϊ°ÐÏòÔËÊä·Ö×Ó¼°ÔØÒ©Ö§¼Ü·Ö×Ó£¬½ñÌìÎÒÃǼÌÐøͨ¹ýÁ½Æª¾«²Ê°¸Àý½éÉÜÍâÃÚÌåĤµ°°×µÄÁÙ´²Ó¦ÓÃDZÄÜ¡£

|   °¸ÀýÒ»:»ùÓÚÍâÃÚÌåĤµ°°×µÄÖÎÁưеãÑо¿

ÍâÃÚÌåÔÚÖ¬·¾¸Î·¢ÉúºÍ½øÕ¹Öз¢»Ó×ŷdz£ÖØÒªµÄ×÷Óã¬Ñо¿Õß·¢ÏÖÁ˾ƾ«ÐÔÖ¬·¾¸Îϸ°û·ÖÃÚµÄÍâÃÚÌå»á¸ß±í´ïϸ°ûÕ³¸½µ°°×ITGβ1£¬½éµ¼µ¥ºËϸ°ûÕ³¸½µ½¸Îñ¼ÄÚƤϸ°û£¬´Ó¶ø´Ù½ø²¡±ä×éÖ¯²¿Î»Ñ×Ö¢µÄ·¢Éú¡£»ùÓÚÍâÃÚÌåITGβ1µÄÖØÒª×÷Óã¬ÔÚNASHСÊóÄ£ÐÍÖи¹Ç»×¢ÉäITGβ1¿¹Ìå¾Í¿ÉÒÔ´ïµ½¼õÇá¸ÎÔàÑ×Ö¢ºÍÏËά»¯µÄÖÎÁÆЧ¹û£¨Í¼1£©¡£Ïà¹ØÑо¿³É¹ûÔÚ2019·¢±íÓڸβ¡Ñ§ÁìÓòµÄ¶¥¼¶ÆÚ¿¯Journal of Hepatology £¨IF£º25.083£©1¡£

ͼ1.ÍâÃÚÌåITGβ1ÔÚNASHÖеÄ×÷ÓûúÖÆ

Ñо¿ÕßÊ×ÏÈ·ÖÀëÁËÔ­´úСÊó¸Îϸ°û£¨PMH£©ÅàÑøÉÏÇåµÄÍâÃÚÌ壬Ȼºóͨ¹ýÍâÃÚÌåµ°°×ÖÊ×éѧ·ÖÎö·¢ÏÖÁËÖ¬¶¾ÐÔ¸Îϸ°ûÀ´Ô´µÄÍâÃÚÌ壨LPC-EV£©¸ß±í´ïºÜ¶àÕûºÏËص°°×£¨Í¼2A£©£¬Ö®ºóÀûÓÃWB¡¢ÃâÒß½ºÌå½ðµç¾µºÍÄÉÃ×Á÷ʽ¶àÖÖ¼¼ÊõÑéÖ¤ÁËÕûºÏËص°°×ITGβ1ÏÔÖøÐԵĸ߱í´ïÔÚLPC-EVÖУ¨Í¼2B-D£©¡£×îºóÑо¿ÕßÀûÓÃÄÉÃ×Á÷ʽ¼¼Êõ·¢ÏÖÁËNASH²¡ÈËѪÇåÍâÃÚÌåÖÐITGβ1µÄ±í´ïÒ²ÏÔÖø¸ßÓÚÆäËûÇá¶ÈÖ¬·¾±äÐÔ²¡ÈË£¨Í¼2E£©£¬»òÐí¿ÉÒÔ×÷ΪNASHµÄÕï¶Ï±êÖ¾Îï¡£

 

ͼ2.µ°°×ÖÊ×éѧ·¢Ï־ƾ«ÐÔÖ¬·¾¸Îϸ°ûÀ´Ô´µÄÍâÃÚÌ帻º¬ITGβ1µ°°×

Ñо¿ÕߺóÐøÏȲûÃ÷ÁËITGβ1¿ÉÒÔͨ¹ýÊÜÌåÄÚÍÌ;¾¶½øÈëÍâÃÚÌ壬֮ºó¿ªÕ¹ÁËÉîÈëµÄ¹¦ÄÜÑо¿¡£Ñо¿Õß·¢ÏÖÁ˱ê¼ÇDiOµÄLPC-EV¿ÉÒÔ±»µ¥ºËϸ°ûÉãÈ¡£¬²¢ÇÒ¿ÉÒÔ´Ù½øµ¥ºËϸ°ûÕ³¸½ÓÚ¸Îñ¼ÄÚƤϸ°û£¨LSEC£©£¨Í¼3A£©£¬ÓëÆäÒ»ÖµÄÊÇת¼×é²âÐò½á¹û·¢ÏÖÁËLPC-EV´¦ÀíµÄLSECÖкܶàºÍϸ°ûÕ³¸½Ïà¹ØµÄ»ùÒò±í´ïÏÔÖøÉϵ÷£¨Í¼3B£©¡£²»¹ÜÊÇÀûÓÃanti-ITGβ1ÖкÍÍâÃÚÌåITGβ1±í´ï£¬»¹ÊÇȱʧITGβ1ϸ°ûÀ´Ô´µÄÍâÃÚÌ嶼»á¼õÈõ´Ùµ¥ºËϸ°ûÕ³¸½µÄ×÷ÓÃЧ¹û£¨Í¼3C£©£¬Ö¤ÊµÁËÍâÃÚÌåÊÇͨ¹ýITGβ1·¢»Ó×÷Ó᣻ùÓÚÍâÃÚÌåITGβ1µÄÌåÍâ×÷ÓÃЧ¹û£¬Ñо¿ÕßÔÚÒûʳÒýÆðµÄNASHСÊóÄ£Ð͸¹Ç»×¢ÉäITGβ1¿¹Ì壬½á¹û·¢ÏÖÁËITGβ1¿¹Ìå¿ÉÒÔ¼õÇáNASHСÊó¸ÎÔàÑ×Ö¢¡¢µ¥ºË¾ÞÊÉϸ°ûµÄÇÖÈó¡¢Ï¸°ûµòÍöºÍÏËά»¯£¨Í¼3D-G£©£¬ËµÃ÷ÁËITGβ1»òÐí¿ÉÒÔ×÷ΪNASHÖÎÁƵÄDZÔڰеã¡£

 

ͼ3. ÍâÃÚÌåITGβ1¿ÉÒÔ×÷ΪNASHÖÎÁƵÄDZÔڰеã

 

|   °¸Àý¶þ:»ùÓÚÍâÃÚÌåĤµ°°×µÄ¿¹²¡¶¾Ñо¿

йڲ¡¶¾£¨SARS-CoV-2£©µÄ´ÌÍ»µ°°×spike (S)¿ÉÒÔÖ±½ÓºÍËÞÖ÷ϸ°ûACE2ÊÜÌå½áºÏ£¬×èÖ¹SºÍACE2µÄ½áºÏÊÇÒÖÖƲ¡¶¾ÈëÇÖ£¬ÖÎÁÆCOVID-19¼²²¡µÄDZÔÚÊֶΡ£½üÆÚËÕÖÝ´óѧÖÜ·¼·¼½ÌÊÚºÍÕã½­´óѧÕÅÁú½ÌÊÚÍŶÓÔÚ²ÄÁÏѧÁìÓòµÄ¶¥¼¶ÆÚ¿¯Advanced Materials£¨IF: 30.849£©·¢±íÁËÒ»Ïî»ùÓÚÍâÃÚÌåĤµ°°×ACE2ÖкÍйڲ¡¶¾ºÍËÞÖ÷ϸ°û½áºÏµÄÑо¿2¡£ËûÃÇ·¢ÏÖµ°°××Øéµõ£»¯ÊÇACE2·ÖÃÚ½øÍâÃÚÌåµÄ¹Ø¼üµ÷¿ØÒòËØ£¬»ùÓÚ´ËËûÃǹ¹½¨Á˸߶È×Øéµõ£»¯µÄACE2£¨PM-ACE2£©Ê¹Æä´óÁ¿·ÖÃÚµ½ÍâÃÚÌåÖУ¬Ö®ºóÔØÓÐPM-ACE2µÄÍâÃÚÌ壨PM-ACE2-EV£©¿ÉÒÔ¾ºÕùÐÔ½áºÏSARS-CoV-2µÄSµ°°×£¬×èÖ¹ÓëËÞÖ÷ϸ°ûµÄ½áºÏ£¬¼õÉÙ²¡¶¾ÈëÇÖ£¨Í¼4£©¡£

 

ͼ4.ÍâÃÚÌåACE2µ°°×¿ÉÒÔÖкͲ¡¶¾ºÍËÞÖ÷ϸ°ûµÄ½áºÏ

Ñо¿ÕßÊ×ÏÈͨ¹ýÍâÃÚÌåµ°°×ÖÊ×éѧȷ¶¨ÁËÔÚVero-E6ϸ°ûºÍMCF7ϸ°ûÀ´Ô´µÄÍâÃÚÌåÖпɼø¶¨µ½ACE2µ°°×£¬µ«ÔÚHEK293Tϸ°ûµÄÍâÃÚÌåÖв¢Ã»Óмø¶¨µ½£¨Í¼5A£©£¬ºóÐøWBÒ²½øÐÐÁËÑéÖ¤£¨5B£©¡£Ö®ºóÀûÓÃÃâÒß½ºÌå½ðµç¾µºÍELISAÑéÖ¤ÁËACE2µ°°×±í´ïÔÚÍâÃÚÌåĤÉÏ£¨Í¼5C,D£©¡£ÖØÒªµÄÊÇÑо¿Õßͨ¹ý±íÃæÉúÎïËØ»¯ÊµÑé·¢ÏÖÁ˲¡¶¾¸ÐȾϸ°û»áÓÕµ¼Ï¸°ûÖÊĤÉϵÄACE2½øÈ¥ÍâÃÚÌåĤÉÏ£¨Í¼5E£©¡£ÎªÁ˽Òʾµ÷¿ØACE2µ°°×½øÈ¥ÍâÃÚÌåµÄ»úÖÆ£¬Ñо¿ÕßÀûÓðÐÏòµ°°×·­ÒëºóÐÞÊεÄ286¸öС·Ö×ÓÒÖÖƼÁ´¦ÀíVero-E6ϸ°û£¬¼ì²âÍâÃÚÌåÖÐACE2µÄ±í´ïÁ¿¡£½á¹û·¢ÏÖÁË×Øéµõ£»¯ÒÖÖƼÁ2-bromopalmitate (2-BP)¿ÉÒÔÏÔÖøÒÖÖÆACE2½øÈ¥ÍâÃÚÌ壬ͬʱȥ×Øéµõ£»¯Ã¸APT1µÄÒÖÖƼÁML348È´¿ÉÒÔÏÔÖø´Ù½øÍâÃÚÌåÖÐACE2µÄ±í´ï£¨Í¼5F£©£¬Ö®ºóÑо¿Õß¿ªÕ¹ÁËÉîÈëµÄ»úÖÆÑо¿£¬·¢ÏÖÁËACE2¹Ø¼üµÄ×Øéµõ£»¯Î»µã£¬²¢ÇÒÌØÒìÐÔµÄÊܵ½×Øéµõ£»¯×ªÒÆøZDHHC3ºÍÈ¥×Øéµõ£»¯Ã¸LYPLA1µÄµ÷¿Ø¡£×ܶøÑÔÖ®£¬ÕâЩ½á¹û˵Ã÷ÁËACE2µÄ×Øéµõ£»¯ÊÇÆä·ÖÃÚ½øÍâÃÚÌåÖеĹؼüµ÷¿ØÒòËØ¡£

 

 

ͼ5.ACE2·ÖÃÚµ½ÍâÃÚÌåÖÐÊܵ½µ°°××Øéµõ£»¯µÄµ÷¿Ø

»ùÓÚÒÔÉϵķ¢ÏÖ£¬Ñо¿Õß¹¹½¨Á˹ý±í´ïÖÊÁ££¬½«Ò»¶Î×Øéµõ£»¯µÄ°ÐÐòÁÐMLCCMRRTKQVÈںϵ½ACE2µÄN¶Ë£¨PM-ACE2£©£¨Í¼6A£©£¬È»ºóתȾµ½MSCϸ°û£¬ÊÕ¼¯Ï¸°ûÍâÃÚÌ壬ͨ¹ýÁ÷ʽ¡¢ÃâÒߵ羵ºÍ ELISAÑéÖ¤ÁËÏà±ÈתȾҰÉúÐÍACE2µÄϸ°û£¬×ªÈ¾PM-ACE2µÄϸ°ûÍâÃÚÌåÖлáÓиü¶àµÄACE2µÄ±í´ï£¨Í¼6B£©¡£Ö®ºóÑо¿ÕßÀûÓñíÃæµÈÀë×Ó¹²Õñ£¨SPR£©ºÍ¾ºÕùELISAʵÑéÖ¤Ã÷ÁËÔØÓÐPM-ACE2µÄÍâÃÚÌ壨PM-ACE2-EV£©¿ÉÒÔ¸ü¼Ó¸ßЧµÄ½áºÏ²¡¶¾Sµ°°×£¬·â±ÕSµ°°×ÓëACE2µ°°×µÄ½áºÏ£¨Í¼6C,D£©¡£

 

ͼ6.PM-ACE2-EV¿ÉÒÔ½áºÏ²¡¶¾Sµ°°×

×îºóÑо¿Õß¼ì²âÁËPM-ACE2-EVÌåÄÚÖкͲ¡¶¾µÄ×÷Ó㬷¢ÏÖÁËÔ¤ÏÈ´¦ÀíPM-ACE2-EV¿ÉÒÔÏÔÖø¼õÉÙSARS-CoV-2¶Ô»úÌåµÄ¸ÐȾ£¨Í¼7A£©£¬¼õÉÙÌåÄÚ¶à¸ö×éÖ¯Öв¡¶¾RNAµÄº¬Á¿£¨Í¼7B£©¡£

 

ͼ7.PM-ACE2-EV¿ÉÒÔ×èÖ¹²¡¶¾ÈëÇÖ

 

|   k8¿­·¢(Öйú)-ÍâÃÚÌå“һվʽ”·þÎñƽ̨

k8¿­·¢(Öйú)×÷ΪÍâÃÚÌå·þÎñÁìÓòµÄר¼Ò£¬ÓµÓжÀÌصÄϵͳÐÔ·þÎñÓÅÊÆ£¬¿ÉʵÏÖÍâÃÚÌåÑо¿µÄ“һվʽ·þÎñ”¡£k8¿­·¢(Öйú)µÄÍâÃÚÌå·þÎñ²úÆ·Ò²»ù±¾À©Õ¹µ½ÁËÍâÃÚÌåÑо¿µÄ·½·½ÃæÃæ¡£ÔÚÍâÃÚÌåµ°°×ÖÊ×éѧ·½Ã棬k8¿­·¢(Öйú)²»½ö¿ÉÒÔÌṩ¸ßÆ·ÖʵÄÖÊÆ×¼¼Êõ·þÎñ£¬¸üÊǽ«ÍâÃÚÌåĤµ°°×¼ì²âµÄÃ÷ÐǼ¼Êõ£ºÄÉÃ×Á÷ʽ¡¢³¬ÁéÃôsimoa¼¼Êõ¡¢¶¨ÖÆ»¯¿¹ÌåоƬ·þÎñÕûºÏÈëÍâÃÚÌåĤµ°°×·þÎñÌåϵÖУ¬ÎªÍâÃÚÌåĤµ°°×±êÖ¾Î↑·¢¡¢ÍâÃÚÌåĤµ°°×°ÐÏòÔØÒ©Ñо¿µÈÌṩ¼¼ÊõÖ§³Å¡£

 

|   ²Î¿¼ÎÄÏ×

1.  Guo Q, Furuta K, Lucien F, Gutierrez Sanchez LH, Hirsova P, Krishnan A et al. Integrin b1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH. J Hepatol. 2019;71(6):1193-1205.

2.  Xie F, Su P, Pan T, Zhou X, Li H, Huang H et al. Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID-19 Therapy. Adv Mater. 2021;e2103471.

k8¿­·¢(Öйú)

µØÖ·£ºÉϺ£ÊÐãÉÐÐÇøÂÌÖÞ»·Â·396Ū5´±4²ã

µç»°£º400-869-2936£¬021-33968791

ÓÊÏ䣺support@wayenbiotech.com

´«Õ棺021-33938792

QQ£º2120485725

Õ½ÂÔºÏ×÷

Õ½ÂÔºÏ×÷

·¢²¼Ê±¼ä£º2021-08-11 17:21:10

|    Full Moon    |    RayBiotech    |    CDI    |    IZON    |    Bio-Rad    |    R&D Systems    |    IsoPlexis    |    ÄÏÄ£ÉúÎï    |    Å·Ò×ÉúÎï    |    ÆäÃ÷ÐÅÏ¢    |    ÃÀ¼ªÉúÎï    |    ÂóÌØ»æÆ×    | 

 

Ìرð˵Ã÷£º±¾ÍøËùÓÐÍøÒ³¾ùΪk8¿­·¢(Öйú)Ô­´´ÐÅÏ¢£¬×ªÔرØÐëÕ÷Çók8¿­·¢(Öйú)ͬÒ⣬²¢Í¬Ê±×¢Ã÷±¾ÍøÃû³Æ¼°ÍøÖ·¡£

רÀû´úÂë

·¢²¼Ê±¼ä£º2023-06-09 17:38:30
Copyright @ 2021 ÉϺ£k8¿­·¢(Öйú)Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾ °æȨËùÓÐ
Record »¦ICP±¸2022031428ºÅ-1
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ÉϺ£
ËÑË÷
ËÑË÷
¹Ø±Õ
¿Í»§ÁôÑÔ
ÑéÖ¤Âë